Programmatic management of latent tuberculosis infection in the European Union
Programmatic management of latent tuberculosis infection (LTBI) is a key component of any tuberculosis elimination strategy, as people with LTBI represent a large human reservoir for the disease. This document provides evidence-based guidance for the implementation of programmatic management of LTBI in the European Union and European Economic Area. The guidance covers four key areas in relation to programmatic management of LTBI: target risk groups; diagnosis; treatment; and programmatic issues of LTBI management.
Related updates on tuberculosis
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries
Health crisis in Venezuela: Status of communicable diseases and implications for the European union and European economic area, may 2019
Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study
Tuberculosis (TB) is a serious infectious disease that can be fatal. It most commonly affects the lungs.Read more
Review of reviews and guidelines on target groups, diagnosis, treatment and programmatic issues for implementation of latent tuberculosis management
15 Oct 2018 - This report is part of a series of technical documents describing the collection, synthesis and appraisal of the available information on specific measures for the prevention, identification and treatment of LTBI, analysed from the perspective of national TB-control programmes.
The sleeping giant: the danger of neglecting latent tuberculosis infection
16 Oct 2018 - The European Centre for Disease Prevention and Control (ECDC) has published comprehensive guidance on the management of latent tuberculosis infection (LTBI) targeted for European Union/European Economic Area (EU/EEA) countries.